FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
09/19/2025
Back to search
Official data from USPTO
ZEVIPTO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
09/20/2025
Trademark type
Word
Nice classes
5
Filing date
11/08/2023
Registration date
02/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
09/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CH
Examiner
CARLYLE, SHAUNIA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above with the exception of pharmaceuticals for the prevention and treatment of central nervous system diseases and disorders
Publications
History of USPTO decisions and trademark events.
36 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/01/2025
FIMP
FINAL DISPOSITION PROCESSED
09/01/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/13/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/27/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/18/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2024
PUBO
PUBLISHED FOR OPPOSITION
12/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2024
ALIE
ASSIGNED TO LIE
11/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2024
NREV
NOTICE OF REVIVAL - E-MAILED
08/15/2024
PETG
PETITION TO REVIVE-GRANTED
08/15/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
08/15/2024
RFNT
REFUSAL PROCESSED BY IB
03/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/13/2024
RFRR
REFUSAL PROCESSED BY MPU
02/13/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/05/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/05/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/25/2024
CNRT
NON-FINAL ACTION WRITTEN
01/24/2024
MAFR
APPLICATION FILING RECEIPT MAILED
01/23/2024
DOCK
ASSIGNED TO EXAMINER
01/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/29/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/28/2023
Continuous trademark protection
Get notified about every new filing that threatens ZEVIPTO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.